Introduction Diabetic retinopathy (DR) and diabetic macular edema (DME) remain leading causes of vision impairment worldwide (1). Contemporary clinical guidelines strongly position intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy as the cornerstone of management for center-involved diabetic macular edema (CI-DME) and an impo
Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
Managing Amenorrhea in Adolescent girl
2554 Reached5 Comments4 Likes
Link between PCOS, Obesity and Diabetes
479 Reached2 Likes